nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CYP2C19—Glyburide—gestational diabetes	0.163	0.432	CbGbCtD
Bortezomib—CYP2C9—Glyburide—gestational diabetes	0.136	0.359	CbGbCtD
Bortezomib—CYP3A4—Glyburide—gestational diabetes	0.079	0.209	CbGbCtD
Bortezomib—PSMA1—embryo—gestational diabetes	0.0158	0.0495	CbGeAlD
Bortezomib—PSMD2—Tolazamide—Glyburide—gestational diabetes	0.0153	0.756	CbGdCrCtD
Bortezomib—Alcohol intolerance—Glyburide—gestational diabetes	0.0152	0.072	CcSEcCtD
Bortezomib—PSMD1—islet of Langerhans—gestational diabetes	0.0138	0.0429	CbGeAlD
Bortezomib—PSMD2—islet of Langerhans—gestational diabetes	0.0122	0.038	CbGeAlD
Bortezomib—PSMB8—islet of Langerhans—gestational diabetes	0.0121	0.0378	CbGeAlD
Bortezomib—PSMD2—embryo—gestational diabetes	0.0118	0.0368	CbGeAlD
Bortezomib—CTSG—adipose tissue—gestational diabetes	0.0109	0.034	CbGeAlD
Bortezomib—Cerebrovascular disorder—Glyburide—gestational diabetes	0.0108	0.0512	CcSEcCtD
Bortezomib—PSMB5—islet of Langerhans—gestational diabetes	0.0107	0.0334	CbGeAlD
Bortezomib—PSMA1—uterus—gestational diabetes	0.0107	0.0334	CbGeAlD
Bortezomib—PSMA1—adipose tissue—gestational diabetes	0.0104	0.0326	CbGeAlD
Bortezomib—Thrombocytopenic purpura—Glyburide—gestational diabetes	0.0103	0.0488	CcSEcCtD
Bortezomib—Leukocytoclastic vasculitis—Glyburide—gestational diabetes	0.00984	0.0467	CcSEcCtD
Bortezomib—PSMB1—islet of Langerhans—gestational diabetes	0.00935	0.0292	CbGeAlD
Bortezomib—PSMB2—islet of Langerhans—gestational diabetes	0.00912	0.0285	CbGeAlD
Bortezomib—CTSG—vagina—gestational diabetes	0.00905	0.0282	CbGeAlD
Bortezomib—PSMB1—embryo—gestational diabetes	0.00904	0.0282	CbGeAlD
Bortezomib—PSMD1—uterus—gestational diabetes	0.00897	0.028	CbGeAlD
Bortezomib—PSMB2—embryo—gestational diabetes	0.00882	0.0275	CbGeAlD
Bortezomib—PSMD1—adipose tissue—gestational diabetes	0.00877	0.0274	CbGeAlD
Bortezomib—Blindness—Glyburide—gestational diabetes	0.00871	0.0413	CcSEcCtD
Bortezomib—Inappropriate antidiuretic hormone secretion—Glyburide—gestational diabetes	0.0083	0.0394	CcSEcCtD
Bortezomib—PSMA1—head—gestational diabetes	0.00802	0.0251	CbGeAlD
Bortezomib—PSMD2—uterus—gestational diabetes	0.00795	0.0248	CbGeAlD
Bortezomib—PSMD2—adipose tissue—gestational diabetes	0.00777	0.0243	CbGeAlD
Bortezomib—PSMB8—adipose tissue—gestational diabetes	0.00772	0.0241	CbGeAlD
Bortezomib—Encephalopathy—Glyburide—gestational diabetes	0.00752	0.0356	CcSEcCtD
Bortezomib—PSMD1—vagina—gestational diabetes	0.00729	0.0228	CbGeAlD
Bortezomib—PSMB5—uterus—gestational diabetes	0.00698	0.0218	CbGeAlD
Bortezomib—PSMB5—adipose tissue—gestational diabetes	0.00682	0.0213	CbGeAlD
Bortezomib—PSMD2—vagina—gestational diabetes	0.00646	0.0202	CbGeAlD
Bortezomib—PSMB8—vagina—gestational diabetes	0.00642	0.02	CbGeAlD
Bortezomib—Cholestasis—Glyburide—gestational diabetes	0.00635	0.0301	CcSEcCtD
Bortezomib—Coagulopathy—Glyburide—gestational diabetes	0.0062	0.0294	CcSEcCtD
Bortezomib—PSMB1—uterus—gestational diabetes	0.0061	0.019	CbGeAlD
Bortezomib—PSMD2—head—gestational diabetes	0.00597	0.0186	CbGeAlD
Bortezomib—PSMB1—adipose tissue—gestational diabetes	0.00596	0.0186	CbGeAlD
Bortezomib—PSMB2—uterus—gestational diabetes	0.00595	0.0186	CbGeAlD
Bortezomib—PSMB2—adipose tissue—gestational diabetes	0.00582	0.0182	CbGeAlD
Bortezomib—PSMB5—vagina—gestational diabetes	0.00567	0.0177	CbGeAlD
Bortezomib—Hyperbilirubinaemia—Glyburide—gestational diabetes	0.00531	0.0252	CcSEcCtD
Bortezomib—SLC31A1—adipose tissue—gestational diabetes	0.00504	0.0157	CbGeAlD
Bortezomib—PSMB8—Glipizide—Glyburide—gestational diabetes	0.00497	0.245	CbGdCrCtD
Bortezomib—PSMB1—vagina—gestational diabetes	0.00496	0.0155	CbGeAlD
Bortezomib—Vasculitis—Glyburide—gestational diabetes	0.00494	0.0234	CcSEcCtD
Bortezomib—PSMB2—vagina—gestational diabetes	0.00484	0.0151	CbGeAlD
Bortezomib—PSMB1—head—gestational diabetes	0.00458	0.0143	CbGeAlD
Bortezomib—PSMB2—head—gestational diabetes	0.00447	0.0139	CbGeAlD
Bortezomib—SLC31A1—vagina—gestational diabetes	0.00419	0.0131	CbGeAlD
Bortezomib—Deafness—Glyburide—gestational diabetes	0.00392	0.0186	CcSEcCtD
Bortezomib—Vascular purpura—Glyburide—gestational diabetes	0.00392	0.0186	CcSEcCtD
Bortezomib—Hepatic failure—Glyburide—gestational diabetes	0.0039	0.0185	CcSEcCtD
Bortezomib—Haemolytic anaemia—Glyburide—gestational diabetes	0.00388	0.0184	CcSEcCtD
Bortezomib—SLC31A1—head—gestational diabetes	0.00387	0.0121	CbGeAlD
Bortezomib—Renal failure acute—Glyburide—gestational diabetes	0.00379	0.018	CcSEcCtD
Bortezomib—Renal impairment—Glyburide—gestational diabetes	0.00368	0.0175	CcSEcCtD
Bortezomib—Dermatitis bullous—Glyburide—gestational diabetes	0.00366	0.0174	CcSEcCtD
Bortezomib—Purpura—Glyburide—gestational diabetes	0.00363	0.0172	CcSEcCtD
Bortezomib—Arthritis—Glyburide—gestational diabetes	0.0036	0.0171	CcSEcCtD
Bortezomib—Hyponatraemia—Glyburide—gestational diabetes	0.00352	0.0167	CcSEcCtD
Bortezomib—Diplopia—Glyburide—gestational diabetes	0.0035	0.0166	CcSEcCtD
Bortezomib—Abdominal distension—Glyburide—gestational diabetes	0.00305	0.0145	CcSEcCtD
Bortezomib—Pancreatitis—Glyburide—gestational diabetes	0.00297	0.0141	CcSEcCtD
Bortezomib—Pancytopenia—Glyburide—gestational diabetes	0.00287	0.0136	CcSEcCtD
Bortezomib—Photosensitivity reaction—Glyburide—gestational diabetes	0.00276	0.0131	CcSEcCtD
Bortezomib—Hepatitis—Glyburide—gestational diabetes	0.00242	0.0115	CcSEcCtD
Bortezomib—Visual impairment—Glyburide—gestational diabetes	0.00233	0.0111	CcSEcCtD
Bortezomib—Eye disorder—Glyburide—gestational diabetes	0.00226	0.0107	CcSEcCtD
Bortezomib—Erythema—Glyburide—gestational diabetes	0.00211	0.01	CcSEcCtD
Bortezomib—Malnutrition—Glyburide—gestational diabetes	0.00211	0.01	CcSEcCtD
Bortezomib—Vision blurred—Glyburide—gestational diabetes	0.00199	0.00943	CcSEcCtD
Bortezomib—Tremor—Glyburide—gestational diabetes	0.00198	0.00937	CcSEcCtD
Bortezomib—Anaemia—Glyburide—gestational diabetes	0.00195	0.00925	CcSEcCtD
Bortezomib—Angioedema—Glyburide—gestational diabetes	0.00193	0.00914	CcSEcCtD
Bortezomib—Leukopenia—Glyburide—gestational diabetes	0.00189	0.00895	CcSEcCtD
Bortezomib—Convulsion—Glyburide—gestational diabetes	0.00183	0.00867	CcSEcCtD
Bortezomib—Myalgia—Glyburide—gestational diabetes	0.0018	0.00852	CcSEcCtD
Bortezomib—Arthralgia—Glyburide—gestational diabetes	0.0018	0.00852	CcSEcCtD
Bortezomib—CYP2C19—vagina—gestational diabetes	0.00177	0.00551	CbGeAlD
Bortezomib—CYP1A1—uterus—gestational diabetes	0.00175	0.00546	CbGeAlD
Bortezomib—Confusional state—Glyburide—gestational diabetes	0.00174	0.00823	CcSEcCtD
Bortezomib—Oedema—Glyburide—gestational diabetes	0.00172	0.00816	CcSEcCtD
Bortezomib—CYP1A1—adipose tissue—gestational diabetes	0.00171	0.00534	CbGeAlD
Bortezomib—Shock—Glyburide—gestational diabetes	0.00169	0.00803	CcSEcCtD
Bortezomib—Nervous system disorder—Glyburide—gestational diabetes	0.00169	0.00801	CcSEcCtD
Bortezomib—Thrombocytopenia—Glyburide—gestational diabetes	0.00169	0.00799	CcSEcCtD
Bortezomib—Hyperhidrosis—Glyburide—gestational diabetes	0.00166	0.00789	CcSEcCtD
Bortezomib—Anorexia—Glyburide—gestational diabetes	0.00164	0.00778	CcSEcCtD
Bortezomib—Hypotension—Glyburide—gestational diabetes	0.00161	0.00763	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00157	0.00744	CcSEcCtD
Bortezomib—Paraesthesia—Glyburide—gestational diabetes	0.00155	0.00733	CcSEcCtD
Bortezomib—CYP2C8—vagina—gestational diabetes	0.00154	0.00481	CbGeAlD
Bortezomib—PTGS1—uterus—gestational diabetes	0.00154	0.0048	CbGeAlD
Bortezomib—Dyspnoea—Glyburide—gestational diabetes	0.00153	0.00728	CcSEcCtD
Bortezomib—Dyspepsia—Glyburide—gestational diabetes	0.00152	0.00719	CcSEcCtD
Bortezomib—PTGS1—adipose tissue—gestational diabetes	0.0015	0.00469	CbGeAlD
Bortezomib—Decreased appetite—Glyburide—gestational diabetes	0.0015	0.0071	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Glyburide—gestational diabetes	0.00149	0.00705	CcSEcCtD
Bortezomib—CYP1A1—vagina—gestational diabetes	0.00142	0.00444	CbGeAlD
Bortezomib—Feeling abnormal—Glyburide—gestational diabetes	0.00142	0.00673	CcSEcCtD
Bortezomib—Gastrointestinal pain—Glyburide—gestational diabetes	0.00141	0.00668	CcSEcCtD
Bortezomib—Urticaria—Glyburide—gestational diabetes	0.00137	0.00649	CcSEcCtD
Bortezomib—Abdominal pain—Glyburide—gestational diabetes	0.00136	0.00645	CcSEcCtD
Bortezomib—CYP1A1—head—gestational diabetes	0.00131	0.0041	CbGeAlD
Bortezomib—Hypersensitivity—Glyburide—gestational diabetes	0.00127	0.00601	CcSEcCtD
Bortezomib—PTGS1—vagina—gestational diabetes	0.00125	0.0039	CbGeAlD
Bortezomib—Asthenia—Glyburide—gestational diabetes	0.00124	0.00586	CcSEcCtD
Bortezomib—Pruritus—Glyburide—gestational diabetes	0.00122	0.00578	CcSEcCtD
Bortezomib—Diarrhoea—Glyburide—gestational diabetes	0.00118	0.00559	CcSEcCtD
Bortezomib—PTGS1—head—gestational diabetes	0.00115	0.0036	CbGeAlD
Bortezomib—Vomiting—Glyburide—gestational diabetes	0.00109	0.00519	CcSEcCtD
Bortezomib—Rash—Glyburide—gestational diabetes	0.00109	0.00515	CcSEcCtD
Bortezomib—Dermatitis—Glyburide—gestational diabetes	0.00108	0.00514	CcSEcCtD
Bortezomib—Headache—Glyburide—gestational diabetes	0.00108	0.00511	CcSEcCtD
Bortezomib—Nausea—Glyburide—gestational diabetes	0.00102	0.00485	CcSEcCtD
Bortezomib—CYP2D6—head—gestational diabetes	0.000949	0.00296	CbGeAlD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—GCK—gestational diabetes	0.000749	0.0106	CbGpPWpGaD
Bortezomib—CYP1A2—Phase II conjugation—GGCT—gestational diabetes	0.000742	0.0105	CbGpPWpGaD
Bortezomib—CYP1A1—Biological oxidations—GGCT—gestational diabetes	0.000681	0.00966	CbGpPWpGaD
Bortezomib—CYP1A1—Tryptophan metabolism—CYP19A1—gestational diabetes	0.00068	0.00965	CbGpPWpGaD
Bortezomib—PTGS1—Overview of nanoparticle effects—TNF—gestational diabetes	0.000634	0.009	CbGpPWpGaD
Bortezomib—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000633	0.00898	CbGpPWpGaD
Bortezomib—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000624	0.00886	CbGpPWpGaD
Bortezomib—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000557	0.0079	CbGpPWpGaD
Bortezomib—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00055	0.00781	CbGpPWpGaD
Bortezomib—CYP1A1—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000543	0.0077	CbGpPWpGaD
Bortezomib—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000512	0.00727	CbGpPWpGaD
Bortezomib—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000508	0.00721	CbGpPWpGaD
Bortezomib—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000504	0.00716	CbGpPWpGaD
Bortezomib—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000498	0.00706	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—LEP—gestational diabetes	0.000479	0.0068	CbGpPWpGaD
Bortezomib—PSMA1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000462	0.00655	CbGpPWpGaD
Bortezomib—PSMD1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000459	0.00652	CbGpPWpGaD
Bortezomib—PSMD2—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000457	0.00649	CbGpPWpGaD
Bortezomib—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00045	0.00639	CbGpPWpGaD
Bortezomib—PSMD2—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000449	0.00637	CbGpPWpGaD
Bortezomib—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000446	0.00633	CbGpPWpGaD
Bortezomib—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000444	0.0063	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—GGCT—gestational diabetes	0.000434	0.00616	CbGpPWpGaD
Bortezomib—CYP1A2—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000434	0.00616	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—GGCT—gestational diabetes	0.000417	0.00592	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—GGCT—gestational diabetes	0.000415	0.00589	CbGpPWpGaD
Bortezomib—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000414	0.00587	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—GGCT—gestational diabetes	0.000413	0.00586	CbGpPWpGaD
Bortezomib—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00041	0.00582	CbGpPWpGaD
Bortezomib—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000409	0.0058	CbGpPWpGaD
Bortezomib—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000409	0.0058	CbGpPWpGaD
Bortezomib—PSMA1—B Cell Activation—FGF2—gestational diabetes	0.000408	0.00579	CbGpPWpGaD
Bortezomib—PSMD1—B Cell Activation—FGF2—gestational diabetes	0.000406	0.00576	CbGpPWpGaD
Bortezomib—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000405	0.00575	CbGpPWpGaD
Bortezomib—PSMD2—B Cell Activation—FGF2—gestational diabetes	0.000404	0.00573	CbGpPWpGaD
Bortezomib—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000365	0.00518	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—GLS2—gestational diabetes	0.000364	0.00517	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—GLS2—gestational diabetes	0.000363	0.00515	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—GLS2—gestational diabetes	0.000361	0.00512	CbGpPWpGaD
Bortezomib—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000351	0.00498	CbGpPWpGaD
Bortezomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00035	0.00497	CbGpPWpGaD
Bortezomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00035	0.00497	CbGpPWpGaD
Bortezomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.00035	0.00497	CbGpPWpGaD
Bortezomib—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000346	0.00491	CbGpPWpGaD
Bortezomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000345	0.0049	CbGpPWpGaD
Bortezomib—PTGS1—Biological oxidations—CYP19A1—gestational diabetes	0.000336	0.00477	CbGpPWpGaD
Bortezomib—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000336	0.00476	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000335	0.00475	CbGpPWpGaD
Bortezomib—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000335	0.00475	CbGpPWpGaD
Bortezomib—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000333	0.00472	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GGCT—gestational diabetes	0.000316	0.00448	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GGCT—gestational diabetes	0.000316	0.00448	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GGCT—gestational diabetes	0.000316	0.00448	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GGCT—gestational diabetes	0.000312	0.00442	CbGpPWpGaD
Bortezomib—PSMB5—B Cell Activation—FGF2—gestational diabetes	0.000309	0.00439	CbGpPWpGaD
Bortezomib—PSMB1—B Cell Activation—FGF2—gestational diabetes	0.000309	0.00439	CbGpPWpGaD
Bortezomib—PSMB2—B Cell Activation—FGF2—gestational diabetes	0.000309	0.00439	CbGpPWpGaD
Bortezomib—PSMB8—B Cell Activation—FGF2—gestational diabetes	0.000305	0.00432	CbGpPWpGaD
Bortezomib—PSMA1—Apoptosis—TNF—gestational diabetes	0.000298	0.00423	CbGpPWpGaD
Bortezomib—PSMD1—Apoptosis—TNF—gestational diabetes	0.000297	0.00421	CbGpPWpGaD
Bortezomib—PSMD2—Apoptosis—TNF—gestational diabetes	0.000296	0.00419	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—MBL2—gestational diabetes	0.000286	0.00405	CbGpPWpGaD
Bortezomib—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000284	0.00403	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—MBL2—gestational diabetes	0.000284	0.00403	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—MBL2—gestational diabetes	0.000283	0.00401	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GLS2—gestational diabetes	0.000276	0.00392	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GLS2—gestational diabetes	0.000276	0.00392	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GLS2—gestational diabetes	0.000276	0.00392	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GLS2—gestational diabetes	0.000272	0.00386	CbGpPWpGaD
Bortezomib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000271	0.00384	CbGpPWpGaD
Bortezomib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000267	0.00379	CbGpPWpGaD
Bortezomib—PSMA1—Disease—RBP4—gestational diabetes	0.000266	0.00377	CbGpPWpGaD
Bortezomib—PSMD1—Disease—RBP4—gestational diabetes	0.000265	0.00375	CbGpPWpGaD
Bortezomib—PSMD2—Disease—RBP4—gestational diabetes	0.000263	0.00374	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—LEPR—gestational diabetes	0.000242	0.00343	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—LEPR—gestational diabetes	0.000241	0.00341	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—LEPR—gestational diabetes	0.000239	0.0034	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NAMPT—gestational diabetes	0.000238	0.00338	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NAMPT—gestational diabetes	0.000237	0.00337	CbGpPWpGaD
Bortezomib—PSMA1—Disease—GCK—gestational diabetes	0.000237	0.00336	CbGpPWpGaD
Bortezomib—CYP1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000237	0.00336	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NAMPT—gestational diabetes	0.000236	0.00335	CbGpPWpGaD
Bortezomib—PSMD1—Disease—GCK—gestational diabetes	0.000236	0.00335	CbGpPWpGaD
Bortezomib—PSMD2—Disease—GCK—gestational diabetes	0.000235	0.00333	CbGpPWpGaD
Bortezomib—CYP1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000234	0.00331	CbGpPWpGaD
Bortezomib—PSMB5—Apoptosis—TNF—gestational diabetes	0.000226	0.00321	CbGpPWpGaD
Bortezomib—PSMB2—Apoptosis—TNF—gestational diabetes	0.000226	0.00321	CbGpPWpGaD
Bortezomib—PSMB1—Apoptosis—TNF—gestational diabetes	0.000226	0.00321	CbGpPWpGaD
Bortezomib—PSMB8—Apoptosis—TNF—gestational diabetes	0.000223	0.00316	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.00022	0.00312	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.00022	0.00312	CbGpPWpGaD
Bortezomib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000219	0.00311	CbGpPWpGaD
Bortezomib—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	0.000217	0.00308	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—MBL2—gestational diabetes	0.000216	0.00307	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—MBL2—gestational diabetes	0.000216	0.00307	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—MBL2—gestational diabetes	0.000216	0.00307	CbGpPWpGaD
Bortezomib—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000214	0.00304	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—MBL2—gestational diabetes	0.000213	0.00303	CbGpPWpGaD
Bortezomib—PSMB5—Disease—RBP4—gestational diabetes	0.000201	0.00286	CbGpPWpGaD
Bortezomib—PSMB1—Disease—RBP4—gestational diabetes	0.000201	0.00286	CbGpPWpGaD
Bortezomib—PSMB2—Disease—RBP4—gestational diabetes	0.000201	0.00286	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—NAMPT—gestational diabetes	0.0002	0.00283	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—NAMPT—gestational diabetes	0.000199	0.00282	CbGpPWpGaD
Bortezomib—PSMB8—Disease—RBP4—gestational diabetes	0.000199	0.00282	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—GCK—gestational diabetes	0.000198	0.00282	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—NAMPT—gestational diabetes	0.000198	0.00281	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—GCK—gestational diabetes	0.000197	0.0028	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—GCK—gestational diabetes	0.000197	0.00279	CbGpPWpGaD
Bortezomib—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	0.000194	0.00275	CbGpPWpGaD
Bortezomib—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000191	0.00271	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MTNR1B—gestational diabetes	0.000191	0.00271	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MTNR1B—gestational diabetes	0.00019	0.0027	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MTNR1B—gestational diabetes	0.000189	0.00269	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—RBP4—gestational diabetes	0.000186	0.00264	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000186	0.00264	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—RBP4—gestational diabetes	0.000185	0.00263	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—RBP4—gestational diabetes	0.000184	0.00262	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—LEPR—gestational diabetes	0.000183	0.0026	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—LEPR—gestational diabetes	0.000183	0.0026	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—LEPR—gestational diabetes	0.000183	0.0026	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—AR—gestational diabetes	0.000182	0.00258	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NAMPT—gestational diabetes	0.000181	0.00256	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NAMPT—gestational diabetes	0.000181	0.00256	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NAMPT—gestational diabetes	0.000181	0.00256	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—AR—gestational diabetes	0.000181	0.00256	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—LEPR—gestational diabetes	0.000181	0.00256	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—AR—gestational diabetes	0.00018	0.00255	CbGpPWpGaD
Bortezomib—PSMB1—Disease—GCK—gestational diabetes	0.00018	0.00255	CbGpPWpGaD
Bortezomib—PSMB5—Disease—GCK—gestational diabetes	0.00018	0.00255	CbGpPWpGaD
Bortezomib—PSMB2—Disease—GCK—gestational diabetes	0.00018	0.00255	CbGpPWpGaD
Bortezomib—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	0.000178	0.00253	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NAMPT—gestational diabetes	0.000178	0.00253	CbGpPWpGaD
Bortezomib—PSMB8—Disease—GCK—gestational diabetes	0.000177	0.00251	CbGpPWpGaD
Bortezomib—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	0.000177	0.00251	CbGpPWpGaD
Bortezomib—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000176	0.0025	CbGpPWpGaD
Bortezomib—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000174	0.00247	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GGCT—gestational diabetes	0.000165	0.00234	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—FGF2—gestational diabetes	0.000164	0.00233	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—FGF2—gestational diabetes	0.000164	0.00232	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—FGF2—gestational diabetes	0.000163	0.00231	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—NAMPT—gestational diabetes	0.000151	0.00215	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—NAMPT—gestational diabetes	0.000151	0.00215	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—NAMPT—gestational diabetes	0.000151	0.00215	CbGpPWpGaD
Bortezomib—CYP1A2—Biological oxidations—CYP19A1—gestational diabetes	0.000151	0.00214	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—GCK—gestational diabetes	0.00015	0.00213	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—GCK—gestational diabetes	0.00015	0.00213	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—GCK—gestational diabetes	0.00015	0.00213	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—NAMPT—gestational diabetes	0.000149	0.00212	CbGpPWpGaD
Bortezomib—CYP1A2—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000149	0.00211	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—GCK—gestational diabetes	0.000148	0.0021	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CYP19A1—gestational diabetes	0.000145	0.00206	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MTNR1B—gestational diabetes	0.000145	0.00205	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MTNR1B—gestational diabetes	0.000145	0.00205	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MTNR1B—gestational diabetes	0.000145	0.00205	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CYP19A1—gestational diabetes	0.000144	0.00205	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GLS2—gestational diabetes	0.000144	0.00205	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CYP19A1—gestational diabetes	0.000144	0.00204	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MTNR1B—gestational diabetes	0.000143	0.00203	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RBP4—gestational diabetes	0.000141	0.002	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RBP4—gestational diabetes	0.000141	0.002	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RBP4—gestational diabetes	0.000141	0.002	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.00014	0.00199	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—gestational diabetes	0.00014	0.00199	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RBP4—gestational diabetes	0.000139	0.00197	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—AR—gestational diabetes	0.000138	0.00195	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—AR—gestational diabetes	0.000138	0.00195	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—AR—gestational diabetes	0.000138	0.00195	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—AR—gestational diabetes	0.000136	0.00192	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.000129	0.00183	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—FGF2—gestational diabetes	0.000125	0.00177	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—FGF2—gestational diabetes	0.000125	0.00177	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—FGF2—gestational diabetes	0.000125	0.00177	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—FGF2—gestational diabetes	0.000123	0.00174	CbGpPWpGaD
Bortezomib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000117	0.00165	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GGCT—gestational diabetes	0.000116	0.00165	CbGpPWpGaD
Bortezomib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000115	0.00163	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CYP19A1—gestational diabetes	0.00011	0.00156	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CYP19A1—gestational diabetes	0.00011	0.00156	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CYP19A1—gestational diabetes	0.00011	0.00156	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CYP19A1—gestational diabetes	0.000108	0.00154	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GGCT—gestational diabetes	0.000107	0.00151	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GLS2—gestational diabetes	0.000102	0.00144	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—FGF2—gestational diabetes	9.97e-05	0.00142	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—FGF2—gestational diabetes	9.93e-05	0.00141	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—FGF2—gestational diabetes	9.88e-05	0.0014	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GGCT—gestational diabetes	9.53e-05	0.00135	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GLS2—gestational diabetes	9.33e-05	0.00132	CbGpPWpGaD
Bortezomib—PSMA1—Disease—FGF2—gestational diabetes	9.21e-05	0.00131	CbGpPWpGaD
Bortezomib—PSMD1—Disease—FGF2—gestational diabetes	9.16e-05	0.0013	CbGpPWpGaD
Bortezomib—PSMD2—Disease—FGF2—gestational diabetes	9.12e-05	0.00129	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.09e-05	0.00129	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GGCT—gestational diabetes	8.76e-05	0.00124	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GGCT—gestational diabetes	8.69e-05	0.00123	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—LEP—gestational diabetes	8.49e-05	0.0012	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—LEP—gestational diabetes	8.45e-05	0.0012	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—LEP—gestational diabetes	8.41e-05	0.00119	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	8.34e-05	0.00118	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GLS2—gestational diabetes	8.33e-05	0.00118	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NAMPT—gestational diabetes	7.91e-05	0.00112	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—GCK—gestational diabetes	7.86e-05	0.00112	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GLS2—gestational diabetes	7.66e-05	0.00109	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GLS2—gestational diabetes	7.59e-05	0.00108	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—FGF2—gestational diabetes	7.56e-05	0.00107	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—FGF2—gestational diabetes	7.56e-05	0.00107	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—FGF2—gestational diabetes	7.56e-05	0.00107	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—FGF2—gestational diabetes	7.45e-05	0.00106	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	7.44e-05	0.00106	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GGCT—gestational diabetes	7.42e-05	0.00105	CbGpPWpGaD
Bortezomib—PSMB5—Disease—FGF2—gestational diabetes	6.98e-05	0.00099	CbGpPWpGaD
Bortezomib—PSMB1—Disease—FGF2—gestational diabetes	6.98e-05	0.00099	CbGpPWpGaD
Bortezomib—PSMB2—Disease—FGF2—gestational diabetes	6.98e-05	0.00099	CbGpPWpGaD
Bortezomib—PSMB8—Disease—FGF2—gestational diabetes	6.88e-05	0.000976	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	6.79e-05	0.000963	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GLS2—gestational diabetes	6.49e-05	0.000921	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—FGF2—gestational diabetes	6.45e-05	0.000915	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—LEP—gestational diabetes	6.43e-05	0.000913	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—LEP—gestational diabetes	6.43e-05	0.000913	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—LEP—gestational diabetes	6.43e-05	0.000913	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—FGF2—gestational diabetes	6.42e-05	0.000911	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—FGF2—gestational diabetes	6.39e-05	0.000906	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—LEP—gestational diabetes	6.34e-05	0.0009	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.8e-05	0.000823	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CYP19A1—gestational diabetes	5.75e-05	0.000816	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GGCT—gestational diabetes	5.73e-05	0.000813	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NAMPT—gestational diabetes	5.57e-05	0.000791	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—GCK—gestational diabetes	5.54e-05	0.000786	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NAMPT—gestational diabetes	5.11e-05	0.000725	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—GCK—gestational diabetes	5.08e-05	0.000721	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GLS2—gestational diabetes	5.01e-05	0.000711	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—FGF2—gestational diabetes	4.89e-05	0.000693	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—FGF2—gestational diabetes	4.89e-05	0.000693	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—FGF2—gestational diabetes	4.89e-05	0.000693	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—FGF2—gestational diabetes	4.82e-05	0.000684	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NAMPT—gestational diabetes	4.56e-05	0.000647	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—GCK—gestational diabetes	4.53e-05	0.000643	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NAMPT—gestational diabetes	4.2e-05	0.000595	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—GCK—gestational diabetes	4.17e-05	0.000592	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NAMPT—gestational diabetes	4.16e-05	0.00059	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—GCK—gestational diabetes	4.13e-05	0.000587	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CYP19A1—gestational diabetes	4.05e-05	0.000575	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CYP19A1—gestational diabetes	3.71e-05	0.000527	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NAMPT—gestational diabetes	3.55e-05	0.000504	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—GCK—gestational diabetes	3.53e-05	0.000501	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CYP19A1—gestational diabetes	3.31e-05	0.00047	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CYP19A1—gestational diabetes	3.05e-05	0.000433	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CYP19A1—gestational diabetes	3.02e-05	0.000429	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NAMPT—gestational diabetes	2.74e-05	0.000389	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—GCK—gestational diabetes	2.73e-05	0.000387	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CYP19A1—gestational diabetes	2.58e-05	0.000367	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	1.99e-05	0.000283	CbGpPWpGaD
